TRAVERE THERAPEUTICS INC

Ticker: TVTX CUSIP: 89422G107 Class: Common Stock

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 21,988 Value ($000) $526 Avg Close $18.80 Range $14.36 - $28.69

Q1 2025

Shares 190,272 Value ($000) $3,410 Avg Close $20.30 Range $16.80 - $25.29

Q3 2024

Shares 1,285,379 Value ($000) $17,982 Avg Close $10.42 Range $7.72 - $15.36

Q2 2023

Shares 326,570 Value ($000) $5,016 Avg Close $18.19 Range $14.51 - $23.18

Q4 2022

Shares 67,349 Value ($000) $1,416 Avg Close $21.19 Range $17.97 - $26.55

Q3 2022

Shares 411,618 Value ($000) $10,143 Avg Close $25.84 Range $22.00 - $29.14

Q2 2022

Shares 301,206 Value ($000) $7,298 Avg Close $25.15 Range $20.80 - $30.35

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	21,988	$526	$18.80	$14.36 - $28.69
Q1 2025	190,272	$3,410	$20.30	$16.80 - $25.29
Q3 2024	1,285,379	$17,982	$10.42	$7.72 - $15.36
Q2 2023	326,570	$5,016	$18.19	$14.51 - $23.18
Q4 2022	67,349	$1,416	$21.19	$17.97 - $26.55
Q3 2022	411,618	$10,143	$25.84	$22.00 - $29.14
Q2 2022	301,206	$7,298	$25.15	$20.80 - $30.35